NCT00295022

Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects

Double-blind, Three Parallel Randomized Groups, Therapeutic Confirmatory Clinical Trial to Compare the Efficacy of Oral Levocetirizine 5 mg and Montelukast 10 mg to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Ragweed Sensitive Subjects Exposed to Ragweed Pollen in an Environmental Exposure Unit (EEU)

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 418 (actual)
• Sponsor: UCB S.A. - Pharma Sector · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To compare the clinical efficacy of levocetirizine 5 mg and montelukast 10 mg on symptoms of seasonal allergic rhinitis occurring in subjects exposed to ragweed pollen in an environmental exposure unit.

Conditions

• Rhinitis, Allergic, Seasonal

Interventions

Type	Name	Description
DRUG	Placebo	* Pharmaceutical form: Over-encapsulated tablet * Route of administration: Oral use
DRUG	Montelukast	* Pharmaceutical form: Over-encapsulated tablet * Concentration: 10 mg * Route of administration: Oral use
DRUG	Levocetirizine	* Pharmaceutical form: Over-encapsulated tablet * Concentration: 5 mg * Route of administration: Oral use

Timeline

• Start date: 2006-07-29
• Primary completion: 2006-10-01
• Completion: 2006-10-01
• First posted: 2006-02-22
• Last updated: 2018-09-11
• Results posted: 2018-07-23

Locations

1 site across 1 country: Canada